• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马里兰州华盛顿县基于社区队列的过氧化物酶体增殖物激活受体基因多态性与心血管发病率和死亡率的关系。

Genetic polymorphisms of peroxisome proliferator-activated receptors and the risk of cardiovascular morbidity and mortality in a community-based cohort in washington county, Maryland.

机构信息

Prevention and Research Center, Weinberg Center for Women's Health and Medicine, Mercy Medical Center, 227 Street Paul Place, 6th Floor, Baltimore, MD 21202, USA.

出版信息

PPAR Res. 2008;2008:276581. doi: 10.1155/2008/276581.

DOI:10.1155/2008/276581
PMID:18288282
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2233806/
Abstract

The primary aim of this study was to examine prospectively the associations between 5 peroxisome proliferator-activated receptor (PPAR) single nucleotide polymorphisms (SNPs) and cardiovascular morbidity and mortality in a community-based cohort study in Washington County, Maryland. Data were analyzed from 9,364 Caucasian men and women participating in CLUE-II. Genotyping on 5 PPAR polymorphisms was conducted using peripheral DNA samples collected in 1989. The followup period was from 1989 to 2003. The results showed that there were no statistically significant associations between the PPAR SNPs and cardiovascular deaths or events. In contrast, statistically significant age-adjusted associations were observed for PPARG rs4684847 with both baseline body mass and blood pressure, and for PPARG rs709158, PPARG rs1175543, and PPARD rs2016520 with baseline cholesterol levels. Future studies should be conducted to confirm these findings and to explore the associations in populations with greater racial and ethnic diversity.

摘要

本研究的主要目的是前瞻性地研究马里兰州华盛顿县社区队列研究中 5 个过氧化物酶体增殖物激活受体(PPAR)单核苷酸多态性(SNP)与心血管发病率和死亡率之间的关系。对参与 CLUE-II 的 9364 名白种男女进行数据分析。1989 年采集外周血 DNA 样本进行 5 个 PPAR 多态性的基因分型。随访期从 1989 年至 2003 年。结果显示,PPAR SNPs 与心血管死亡或事件之间无统计学显著相关性。相反,PPARG rs4684847 与基线体重和血压,以及 PPARG rs709158、PPARG rs1175543 和 PPARD rs2016520 与基线胆固醇水平之间存在统计学显著的年龄调整相关性。未来的研究应进行以确认这些发现,并探索在种族和民族多样性更大的人群中的相关性。

相似文献

1
Genetic polymorphisms of peroxisome proliferator-activated receptors and the risk of cardiovascular morbidity and mortality in a community-based cohort in washington county, Maryland.马里兰州华盛顿县基于社区队列的过氧化物酶体增殖物激活受体基因多态性与心血管发病率和死亡率的关系。
PPAR Res. 2008;2008:276581. doi: 10.1155/2008/276581.
2
Single nucleotide polymorphisms in inflammation-related genes and mortality in a community-based cohort in Washington County, Maryland.马里兰州华盛顿县一个社区队列中炎症相关基因的单核苷酸多态性与死亡率
Am J Epidemiol. 2008 Apr 1;167(7):807-13. doi: 10.1093/aje/kwm378. Epub 2008 Feb 7.
3
Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study.肥胖相关基因中的单核苷酸多态性与全因死亡率和特定病因死亡率:一项前瞻性队列研究。
BMC Med Genet. 2009 Oct 9;10:103. doi: 10.1186/1471-2350-10-103.
4
[Association of both peroxisome proliferator-activated receptor, gene-gene interactions and the body mass index].[过氧化物酶体增殖物激活受体、基因-基因相互作用与体重指数的关联]
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jul;33(7):740-5.
5
[Association and interaction of peroxisome proliferator-activated receptor α with low high-density lipoprotein hyperlipidemia and with peroxisome proliferator-activated receptor γ].过氧化物酶体增殖物激活受体α与低高密度脂蛋白血症以及与过氧化物酶体增殖物激活受体γ的关联和相互作用
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Dec;33(12):1218-23.
6
[Association between peroxisome proliferator-activated receptors gene polymorphism and essential hypertension].过氧化物酶体增殖物激活受体基因多态性与原发性高血压的关联
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jun;33(6):597-601.
7
Association between peroxisome proliferator-activated receptor-alpha, -delta and -gamma gene () polymorphisms and overweight parameters in physically active men.过氧化物酶体增殖物激活受体α、δ和γ基因()多态性与体力活动男性超重参数之间的关联。
Biol Sport. 2021 Oct;38(4):767-776. doi: 10.5114/biolsport.2022.109957. Epub 2021 Dec 28.
8
Peroxisome proliferator-activated receptor (PPAR) isoforms are differentially expressed in peri-implantation porcine conceptuses.过氧化物酶体增殖物激活受体(PPAR)亚型在猪着床前的孕体中差异表达。
Theriogenology. 2017 Oct 1;101:53-61. doi: 10.1016/j.theriogenology.2017.06.013. Epub 2017 Jun 13.
9
[Association and interaction between 10 SNP of peroxisome proliferator-activated receptor and non-HDL-C].[过氧化物酶体增殖物激活受体10个单核苷酸多态性与非高密度脂蛋白胆固醇的关联及相互作用]
Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Mar;49(3):259-64.
10
[Association and effects of gene-gene interactions between peroxisome proliferator-activated receptor and pulse pressure].[过氧化物酶体增殖物激活受体与脉压之间基因-基因相互作用的关联及影响]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Oct 10;38(10):1404-1409. doi: 10.3760/cma.j.issn.0254-6450.2017.10.022.

引用本文的文献

1
Distinct Roles of Common Genetic Variants and Their Contributions to Diabetes: MODY and Uncontrolled T2DM.常见基因变异的不同作用及其对糖尿病的影响:青少年发病的成年型糖尿病和未控制的2型糖尿病
Biomolecules. 2025 Mar 14;15(3):414. doi: 10.3390/biom15030414.
2
Interactive Associations between and and Bisphosphonate-Related Osteonecrosis of the Jaw in Patients with Osteoporosis.骨质疏松症患者中[具体内容缺失]与[具体内容缺失]及双膦酸盐相关颌骨坏死之间的交互关联。
Pharmaceuticals (Basel). 2023 Jul 21;16(7):1035. doi: 10.3390/ph16071035.
3
Pharmacological Utility of PPAR Modulation for Angiogenesis in Cardiovascular Disease.PPAR 调节在心血管疾病血管生成中的药理学作用。
Int J Mol Sci. 2023 Jan 25;24(3):2345. doi: 10.3390/ijms24032345.
4
PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease.过氧化物酶体增殖物激活受体γ基因多态性、代谢紊乱与冠状动脉疾病
Front Cardiovasc Med. 2022 Mar 23;9:808929. doi: 10.3389/fcvm.2022.808929. eCollection 2022.
5
Leveraging Genomic Associations in Precision Digital Care for Weight Loss: Cohort Study.利用基因组关联在精准数字减肥护理中的应用:队列研究。
J Med Internet Res. 2021 May 19;23(5):e25401. doi: 10.2196/25401.
6
Haplotype Analysis of PPARγ Gene Polymorphisms and the Lipoprotein (a) Level.PPARγ基因多态性与脂蛋白(a)水平的单倍型分析
Iran J Public Health. 2018 Jul;47(7):973-979.
7
Nutrigenomic Functions of PPARs in Obesogenic Environments.过氧化物酶体增殖物激活受体(PPARs)在致肥胖环境中的营养基因组学功能。
PPAR Res. 2016;2016:4794576. doi: 10.1155/2016/4794576. Epub 2016 Nov 30.
8
Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.评估PPARβ/δ(PPARD)功能的综合与系统方法。
Nucl Recept Signal. 2015 Apr 27;13:e001. doi: 10.1621/nrs.13001. eCollection 2015.
9
Haplotype analysis of PPARγ C681G and intron CT variants. Positive association with essential hypertension.PPARγ C681G和内含子CT变异的单倍型分析。与原发性高血压呈正相关。
Herz. 2014 Mar;39(2):264-70. doi: 10.1007/s00059-013-3819-x. Epub 2013 May 9.
10
Peroxisome proliferator-activated receptor gamma polymorphisms and coronary heart disease.过氧化物酶体增殖物激活受体 γ 多态性与冠心病。
PPAR Res. 2009;2009:543746. doi: 10.1155/2009/543746. Epub 2009 Dec 1.

本文引用的文献

1
Frequencies of single nucleotide polymorphisms in genes regulating inflammatory responses in a community-based population.基于社区人群中调节炎症反应基因的单核苷酸多态性频率。
BMC Genet. 2007 Mar 14;8:7. doi: 10.1186/1471-2156-8-7.
2
No association of Pro12Ala polymorphism of PPAR-gamma gene with coronary artery disease in Korean subjects.韩国人群中PPAR-γ基因Pro12Ala多态性与冠状动脉疾病无关联。
Circ J. 2007 Mar;71(3):338-42. doi: 10.1253/circj.71.338.
3
Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.2型糖尿病相关的PPARG P12A基因多态性对糖尿病进展及曲格列酮反应的影响。
J Clin Endocrinol Metab. 2007 Apr;92(4):1502-9. doi: 10.1210/jc.2006-2275. Epub 2007 Jan 9.
4
PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases.过氧化物酶体增殖物激活受体:中风和神经退行性疾病中神经保护的新药理学靶点。
Biochem Soc Trans. 2006 Dec;34(Pt 6):1341-6. doi: 10.1042/BST0341341.
5
Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population.中国汉族人群中过氧化物酶体增殖物激活受体γ2基因Pro12Ala多态性与心肌梗死的关联
Clin Cardiol. 2006 Jul;29(7):300-4. doi: 10.1002/clc.4960290706.
6
Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.血管生物学中的过氧化物酶体增殖物激活受体——分子机制与临床意义
Vascul Pharmacol. 2006 Jul;45(1):19-28. doi: 10.1016/j.vph.2005.11.014. Epub 2006 Jun 16.
7
C47T polymorphism in manganese superoxide dismutase (MnSOD), antioxidant intake and survival.锰超氧化物歧化酶(MnSOD)中的C47T多态性、抗氧化剂摄入量与生存率。
Mech Ageing Dev. 2006 Apr;127(4):371-7. doi: 10.1016/j.mad.2005.12.006. Epub 2006 Feb 3.
8
The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics.过氧化物酶体增殖物激活受体(PPAR)基因、心血管疾病与PPAR药物遗传学的出现
Expert Opin Pharmacother. 2005 Dec;6(15):2577-91. doi: 10.1517/14656566.6.15.2577.
9
Peroxisome proliferator-activated receptor-gamma2 P12A polymorphism and risk of coronary heart disease in US men and women.过氧化物酶体增殖物激活受体γ2 P12A多态性与美国男性和女性冠心病风险
Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1654-8. doi: 10.1161/01.ATV.0000171993.78135.7e. Epub 2005 May 26.
10
PPARs: therapeutic targets for metabolic disease.过氧化物酶体增殖物激活受体:代谢性疾病的治疗靶点
Trends Pharmacol Sci. 2005 May;26(5):244-51. doi: 10.1016/j.tips.2005.03.003.